A. Lyndsay Drayer

547 total citations
17 papers, 451 citations indexed

About

A. Lyndsay Drayer is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, A. Lyndsay Drayer has authored 17 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in A. Lyndsay Drayer's work include Acute Myeloid Leukemia Research (7 papers), Platelet Disorders and Treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). A. Lyndsay Drayer is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Platelet Disorders and Treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). A. Lyndsay Drayer collaborates with scholars based in Netherlands and United Kingdom. A. Lyndsay Drayer's co-authors include Edo Vellenga, Gwenny M. Fuhler, Sandra Olthof, Arjen‐Kars Boer, Nel R. Blom, Hallgeir Rui, Jan Jacob Schuringa, Paul J. Coffer, Szabolcs Fátrai and Mariet T. Esselink and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Stem Cells.

In The Last Decade

A. Lyndsay Drayer

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lyndsay Drayer Netherlands 14 212 150 141 135 62 17 451
Leiv Sindre Rusten Norway 11 270 1.3× 206 1.4× 220 1.6× 116 0.9× 65 1.0× 14 555
Yuichi Konuma Japan 9 176 0.8× 184 1.2× 61 0.4× 142 1.1× 91 1.5× 16 490
Carlo Zibera Italy 14 133 0.6× 117 0.8× 222 1.6× 222 1.6× 69 1.1× 28 602
M Poncz United States 10 286 1.3× 207 1.4× 132 0.9× 90 0.7× 90 1.5× 15 581
S. J. Gadd Austria 9 109 0.5× 162 1.1× 164 1.2× 80 0.6× 23 0.4× 13 478
Kazuhide Misawa Japan 5 70 0.3× 213 1.4× 173 1.2× 228 1.7× 48 0.8× 8 467
Bożena Jaźwiec Poland 15 186 0.9× 219 1.5× 165 1.2× 102 0.8× 90 1.5× 56 536
Marianna Greco Italy 13 94 0.4× 125 0.8× 90 0.6× 79 0.6× 59 1.0× 30 420
Maxim Kebenko Germany 12 135 0.6× 243 1.6× 165 1.2× 265 2.0× 62 1.0× 30 609
Rana Baraz Australia 10 237 1.1× 227 1.5× 185 1.3× 174 1.3× 67 1.1× 13 559

Countries citing papers authored by A. Lyndsay Drayer

Since Specialization
Citations

This map shows the geographic impact of A. Lyndsay Drayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lyndsay Drayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lyndsay Drayer more than expected).

Fields of papers citing papers by A. Lyndsay Drayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lyndsay Drayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lyndsay Drayer. The network helps show where A. Lyndsay Drayer may publish in the future.

Co-authorship network of co-authors of A. Lyndsay Drayer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lyndsay Drayer. A scholar is included among the top collaborators of A. Lyndsay Drayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lyndsay Drayer. A. Lyndsay Drayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fuhler, Gwenny M., et al.. (2009). Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells. European Journal Of Haematology. 83(3). 235–245. 34 indexed citations
2.
Vellenga, Edo, Gwenny M. Fuhler, A. Lyndsay Drayer, et al.. (2009). cells from patients with myelodysplasia + migration of CD34 contributes to an impairment of stromal cellderived factor-1induced Reduced activation of protein kinase B, Rac, and F-actin polymerization. 1 indexed citations
3.
4.
Kruit, Janine K., A. Lyndsay Drayer, Vincent W. Bloks, et al.. (2007). Plant Sterols Cause Macrothrombocytopenia in a Mouse Model of Sitosterolemia. Journal of Biological Chemistry. 283(10). 6281–6287. 34 indexed citations
5.
6.
Fuhler, Gwenny M., Nel R. Blom, Paul J. Coffer, A. Lyndsay Drayer, & Edo Vellenga. (2006). The reduced GM-CSF priming of ROS production in granulocytes from patients with myelodysplasia is associated with an impaired lipid raft formation. Journal of Leukocyte Biology. 81(2). 449–457. 21 indexed citations
7.
8.
Drayer, A. Lyndsay, Sandra Olthof, & Edo Vellenga. (2005). Mammalian Target of Rapamycin Is Required for Thrombopoietin-Induced Proliferation of Megakaryocyte Progenitors. Stem Cells. 24(1). 105–114. 33 indexed citations
9.
10.
11.
Boer, Arjen‐Kars, A. Lyndsay Drayer, & Edo Vellenga. (2003). Stem cell factor enhances erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway. Experimental Hematology. 31(6). 512–520. 17 indexed citations
12.
Fuhler, Gwenny M., et al.. (2003). Reduced expression of flavocytochrome b558, a component of the NADPH oxidase complex, in neutrophils from patients with myelodysplasia. Experimental Hematology. 31(9). 752–759. 10 indexed citations
13.
Boer, Arjen‐Kars, A. Lyndsay Drayer, & Edo Vellenga. (2003). cAMP/PKA-mediated Regulation of Erythropoiesis. Leukemia & lymphoma. 44(11). 1893–1901. 16 indexed citations
14.
Fuhler, Gwenny M., A. Lyndsay Drayer, & Edo Vellenga. (2003). Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia. Blood. 101(3). 1172–1180. 45 indexed citations
15.
Boer, Arjen‐Kars, A. Lyndsay Drayer, Hallgeir Rui, & Edo Vellenga. (2002). Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Blood. 100(2). 467–473. 46 indexed citations
16.
Drayer, A. Lyndsay, et al.. (2001). Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells. Leukemia. 15(11). 1750–1757. 19 indexed citations
17.
Drayer, A. Lyndsay, Cees Th. Smit Sibinga, Nel R. Blom, J. Th. M. de Wolf, & Edo Vellenga. (2000). The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors. British Journal of Haematology. 109(4). 776–784. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leiv Sindre Rusten Breakdown of academic impact, for papers by Yuichi Konuma Breakdown of academic impact, for papers by Carlo Zibera Breakdown of academic impact, for papers by M Poncz Breakdown of academic impact, for papers by S. J. Gadd Breakdown of academic impact, for papers by Kazuhide Misawa Breakdown of academic impact, for papers by Bożena Jaźwiec Breakdown of academic impact, for papers by Marianna Greco Breakdown of academic impact, for papers by Maxim Kebenko Breakdown of academic impact, for papers by Rana Baraz
Rankless by CCL
2026